Literature DB >> 21200169

Platelet-rich plasma treatment for ligament and tendon injuries.

Justin Paoloni1, Robert J De Vos, Bruce Hamilton, George A C Murrell, John Orchard.   

Abstract

Platelet-rich plasma (PRP) is derived from centrifuging whole blood, has a platelet concentration higher than that of the whole blood, is the cellular component of plasma that settles after centrifugation, and contains numerous growth factors. There is increasing interest in the sports medicine and athletic community about providing endogenous growth factors directly to the injury site, using autologous blood products such as PRP, to potentially facilitate healing and earlier return to sport after musculoskeletal injury. Despite this interest, and apparent widespread use, there is a lack of high-level evidence regarding randomized clinical trials assessing the efficacy of PRP in treating ligament and tendon injuries. Basic science and animal studies and small case series reports on PRP injections for ligament or tendon injuries, but few randomized controlled clinical trials have assessed the efficacy of PRP injections and none have demonstrated scientific evidence of efficacy. Scientific studies should be performed to assess clinical indications, efficacy, and safety of PRP, and this will require appropriately powered randomized controlled trials with adequate and validated clinical and functional outcome measures and sound statistical analysis. Other aspects of PRP use that need to be determined are (1) volume of injection/application, (2) most effective preparation, (3) buffering/activation, (4) injection technique (1 depot vs multiple depots), (5) timing of injection to injury, (6) single application versus series of injections, and (7) the most effective rehabilitation protocol to use after PRP injection. With all proposed treatments, the doctor and the patient should weigh up potential benefits of treatment, potential risks, and costs. Based on the limited publications to date and theoretical considerations, the potential risks involved with PRP are fortunately very low. However, benefits remain unproven to date, particularly when comparing PRP with other injections for ligament and tendon injuries.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21200169     DOI: 10.1097/JSM.0b013e31820758c7

Source DB:  PubMed          Journal:  Clin J Sport Med        ISSN: 1050-642X            Impact factor:   3.638


  27 in total

Review 1.  Augmenting tendon and ligament repair with platelet-rich plasma (PRP).

Authors:  Ting Yuan; Chang-Qing Zhang; James H-C Wang
Journal:  Muscles Ligaments Tendons J       Date:  2013-08-11

Review 2.  Musculoskeletal diseases--tendon.

Authors:  Tomoya Sakabe; Takao Sakai
Journal:  Br Med Bull       Date:  2011-07-04       Impact factor: 4.291

3.  Efficacy of intra-tendinous injection of platelet-rich plasma in treating tendinosis: comprehensive assessment of a rat model.

Authors:  Benjamin Dallaudière; Marta Lempicki; Lionel Pesquer; Liliane Louedec; Pierre Marie Preux; Philippe Meyer; Vincent Hummel; Ahmed Larbi; Lydia Deschamps; Clement Journe; Agathe Hess; Alain Silvestre; Paul Sargos; Philippe Loriaut; Patrick Boyer; Elisabeth Schouman-Claeys; Jean Baptiste Michel; Jean Michel Serfaty
Journal:  Eur Radiol       Date:  2013-06-26       Impact factor: 5.315

4.  Platelet-rich plasma induces annulus fibrosus cell proliferation and matrix production.

Authors:  T N Pirvu; J E Schroeder; M Peroglio; S Verrier; L Kaplan; R G Richards; M Alini; S Grad
Journal:  Eur Spine J       Date:  2014-01-28       Impact factor: 3.134

5.  Ultrasound-guided platelet-rich plasma injection for distal biceps tendinopathy.

Authors:  Scott L Barker; Simon N Bell; David Connell; Jennifer A Coghlan
Journal:  Shoulder Elbow       Date:  2015-01-16

Review 6.  State-of-the-Art management of knee osteoarthritis.

Authors:  Kenton H Fibel; Howard J Hillstrom; Brian C Halpern
Journal:  World J Clin Cases       Date:  2015-02-16       Impact factor: 1.337

7.  The Effect of Autologous Platelet Rich Plasma in the Treatment of Achilles Tendon Ruptures: An Experimental Study on Rabbits.

Authors:  Baran Şen; Serkan Güler; Berivan Çeçen; Erdem Kumtepe; Alper Bağrıyanık; Sermin Özkal; M Ali Özcan; Hayri Özsan; Namık Şanlı; M Hasan Tatari
Journal:  Balkan Med J       Date:  2016-01-01       Impact factor: 2.021

Review 8.  Inflammatory mechanisms in tendinopathy - towards translation.

Authors:  Neal L Millar; George A C Murrell; Iain B McInnes
Journal:  Nat Rev Rheumatol       Date:  2017-01-25       Impact factor: 20.543

9.  Rehabilitation of a partially torn distal triceps tendon after platelet rich plasma injection: a case report.

Authors:  Scott W Cheatham; Morey J Kolber; Paul A Salamh; William J Hanney
Journal:  Int J Sports Phys Ther       Date:  2013-06

10.  Low-level laser therapy combined with platelet-rich plasma on the healing calcaneal tendon: a histological study in a rat model.

Authors:  Danillo Barbosa; Renato Aparecido de Souza; Wellington Roberto Gomes de Carvalho; Murilo Xavier; Paula Kariluce de Carvalho; Tereza Cristina Rodrigues Cunha; Emilia Ângela Loschiavo Arisawa; Landulfo Silveira; Antonio Balbin Villaverde
Journal:  Lasers Med Sci       Date:  2013-01-10       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.